Tuberkulozni limfadenitis – još uvek na sceni
Sažetak
Uvod. Tuberkuloza (TB) i dalje predstavlja globalni zdravstveni problem, sa različitim manifestacijama koje utiču na različite organe i organske sisteme. Tuberkulozni limfadenitis (TBL), poznat i kao škrofula ili TB limfnih čvorova (LČ), manifestacija je infekcije Mycobacterium tuberculosis, koja prvenstveno zahvata LČ. Naš region ima nisku godišnju stopu incidencije TB, zbog čega je niska i očekivana prevalencija TBL. Prikaz bolesnika. Prikazana su dva slučaja TBL-a, koja smo dijagnostikovali u razmaku od tri meseca. Oba prikazana bolesnika imala su bolest lokalizovanu u LČ vrata. Radilo se o mladim osobama bez hroničnih bolesti, koje su prethodno bile u dobrom zdravstvenom stanju. Dijagnoza je kod prvog bolesnika potvđena hirurškom biopsijom LČ, a kod drugog bolesnika aspiracionom biopsijom „finom iglom“. Oba bolesnika lečena su standardnim protokolima za TBL, sa povoljnim ishodom i bez značajnih komplikacija i neželjenih efekata terapije. Zaključak. Prikazani slučajevi potvrđuju važnost razmatranja TBL u diferencijalnoj dijagnozi izraslina na vratu, čak i u regionima sa niskom prevalencijom TB. Pravovremena dijagnoza i lečenje su ključni za sprečavanje komplikacija i postizanje uspešnog ishoda lečenja.
Reference
World Health Organization. Global tuberculosis report 2022 [In-ternet]. Geneva: WHO; 2022 [accessed on 2024 Sept 17]. Available from: https://www.who.int/teams/global-tubercul
osis-programme/tb-reports/global-tuberculosis-report-2022
World Health Organization. Tuberculosis [Internet]. Geneva: WHO; 2023 [accessed on 2024 Sept 26]. Available from:
https://www.who.int/health-topics/tuberculosis#tab=tab_1
Institute of Public Health of Serbia Dr Milan Jovanović Batut. Com-municable diseases in Republic of Serbia [Internet]. Belgrade: Batut; 2023 [accessed on 2024 Sept 26]. Available from: https:
//www.batut.org.rs/download/publikacije/pub2022v1.pdf
Pešut D, Bulajić M, Lešić A. Time trend and clinical pattern of extrapulmonary tuberculosis in Serbia, 1993–2007. Vojnosan-it Pregl 2012; 69(3): 227–30.
Lawn SD, Zumla AI. Tuberculosis. Lancet 2011; 378(9785): 57–72.
Barberis I, Bragazzi NL, Galluzzo L, Martini M. The history of tuberculosis: from the first historical records to the isolation of Koch's bacillus. J Prev Med Hyg 2017; 58(1): E9–12.
Karleen C, Saniasiaya J. Cervical tuberculous lymphadenitis. BMJ Case Rep 2021; 14(5): e241807.
Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL, Catta-manchi A, et al. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Soci-ety of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. Clin Infect Dis 2016; 63(7): e147–95.
Sharma SK, Ryan H, Khaparde S, Sachdeva KS, Singh AD, Mohan A, et al. Index-TB guidelines: Guidelines on extrapulmonary tuberculosis for India. Indian J Med Res 2017; 145(4): 448–63.
Hashmi AA, Naz S, Ahmed O, Yaqeen SR, Irfan M, Kamal A, et al. Utility of Fine Needle Aspiration Cytology in the Evalua-tion of Lymphadenopathy. Cureus 2020; 12(12): e11990.
Hauk L. Tuberculosis: Guidelines for Diagnosis from the ATS, IDSA, and CDC. Am Fam Physician 2018; 97(1): 56–8.
Caminero JA, de March P. Statements of ATS, CDC, and IDSA on treatment of tuberculosis. Am J Respir Crit Care Med 2004; 169(2): 316–7.
Lemus LF, Revelo E. Cervical Tuberculous Lymphadenitis. Cu-reus 2022; 14(11): e31282.
Milic R, Lazovic Popovic B, Lalic N, Sarac S. Life-Threatening Hemoptysis Leading to Suffocation. Cureus 2024; 16(2): e55001.
Chorath K, Rajasekaran K. Evaluation and management of a neck mass. Med Clin North Am 2021; 105(5): 827–37.
Gautam H, Agrawal SK, Verma SK, Singh UB. Cervical tuber-culous lymphadenitis: Clinical profile and diagnostic modali-ties. Int J Mycobacteriol 2018; 7(3): 212–6.
Rabahi MF, Silva Junior JLRD, Ferreira ACG, Tannus-Silva DGS, Conde MB. Tuberculosis treatment. J Bras Pneumol 2017; 43(6): 472–86. Erratum in: J Bras Pneumol 2018; 44(4): 340.
Cole B, Nilsen DM, Will L, Etkind SC, Burgos M, Chorba T. Es-sential Components of a Public Health Tuberculosis Preven-tion, Control, and Elimination Program: Recommendations of the Advisory Council for the Elimination of Tuberculosis and the National Tuberculosis Controllers Association. MMWR Recomm Rep 2020; 69(7): 1–27.